AR and posterior cortical atrophy: Despite the widespread use and contributions of several cell lines in molecular urology research (e.g. AR de-regulation), there are major limitations in their applications in terms of discovery and validation of clinically relevant biomarkers and as robust platforms for drug testing in a pre-clinical set-up, for instance, due to the high variability of biomarker expression in various PCa and CRPC cells9,10.